Diseases, Conditions, Syndromes

TB drug price slashed in global push to thwart killer disease

A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world's deadliest infectious disease, as a new treatment was also set to begin extensive testing.

Neuroscience

Advanced brain investigations can become better and cheaper

(Medical Xpress)—An important method for brain research and diagnosis is magnetoencephalography (MEG). But the MEG systems are so expensive that not all EU countries have one today. A group of Swedish researchers are now ...

Medications

How new model boosts supply and lowers prices for generic drugs

Civica Rx, a not-for profit drug manufacturer founded by seven US health systems and three philanthropic organizations, increased supply security and lowered cost on aggregate for 20 drug products, according to the first ...

Medications

New drug assessment program to offer value-based price benchmark

With drug prices for cancer and many other conditions soaring to new highs amid questions about their true value to patients, the Institute for Clinical and Economic Review (ICER) today launched a program to transform the ...

Health

As hospitals post price lists, the public is asked to check them

Federal officials required hospitals nationwide this year to post their "list" prices online. But it's not yet clear how many are doing it, even as the government has taken the rare step of asking consumers to monitor hospital ...

Other

US wants more information from Roche on Illumina bid

Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.

page 1 from 2